TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Reliability of scapular positioning measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Occurrence of AF after AFL ablation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Satisfaction scores for labour analgesia
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: treatment mortality
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in pSTAT1(+) cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreases in IL-23/TH17 pathways
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in nonmotile microbial count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction in motile microbial count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Weight and appearance satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Negative affect (NA)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Corneal endothelial cell loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Improvements in the WMFT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvements in the CKS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serious bleeding rates during infusion
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment-emergent bleeding rates during infusion
Endpoint domain: Adverse events/effects
Primary endpoint: improvement in motor scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in long-term verbal and visual memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TB risk
Endpoint domain: Adverse events/effects
Primary endpoint: new-onset diabetes or death
Endpoint domain: Mortality/survival
Primary endpoint: Development of cholestasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Survival with favorable neurologic status
Endpoint domain: Mortality/survival
Primary endpoint: Improvement on the NYU-CIBIC-Plus
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Participant attitudes regarding examination discomfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maintenance or improvement in neurological status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Angular motion maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Response to adenosine challenges
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extrathoracic AHR prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TA response time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of co-contraction of antagonist muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean duration of ischemia per hour of monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: pain control postoperatively
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Birth weight adjusted for gestational age
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uterine artery volumetric flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fetal fat mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ILAS score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Participation rate of eligible caregivers
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Attainment of personal goals after the program
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: likelihood of developing new lesions
Endpoint domain: Adverse events/effects
Primary endpoint: bacteriological cure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gain in H-SDS CA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: final height prognosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in total PASI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response defined as decrease in total PASI of at least 50%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: onset of anemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RBC transfusion requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of sites with bleeding on probing (BoP+)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: METs improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vertical position of the gonion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lifetime depressive disorder odds
Endpoint domain: Mortality/survival
Primary endpoint: Recurrent unipolar depressive disorder odds
Endpoint domain: Mortality/survival
Primary endpoint: Prevalence of alcoholism and substance use disorders
Endpoint domain: Adverse events/effects
Primary endpoint: Cardiovascular adverse outcomes
Endpoint domain: Adverse events/effects
Primary endpoint: Mucosal changes in cirrhotic patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: annual risk of de novo hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Area under the curve for high-sensitivity C-reactive protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metastasis and recurrence rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cumulative incidence of herpes zoster
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: NIH-CPSI total score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PPVR (Post-Procedure Volume Ratio)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Late and very late stent thrombosis (ST)
Endpoint domain: Adverse events/effects
Primary endpoint: Patch EE median AUC 0-168 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pill EE median AUC 0-48 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patch NGMN AUC 0-168 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: all-cause death or HF event
Endpoint domain: Mortality/survival
Primary endpoint: RT-ARD score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TBA-MDA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annual costs of nefazodone treatment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cost per successfully treated patient
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Improvement in Dermatology Life Quality Index
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Prevalence of precancerous gastric lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of gastric cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Peak INR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: pulmonary function preservation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Comfort level watching themselves
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Agreement that clinical skills would improve
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perception of improvement in clinical skills after OSCE
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: angiographic vasospasm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: delayed ischemic neurological deficit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cortical activation during working memory and selective attention tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: VAS score indicating sedative effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Behavioral performance during working memory and visual perception tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IgA concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: IgA secretory rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Ratio of cup area:disc area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to hemostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: bronchodilator efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Cumulative MACE rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of ST
Endpoint domain: Adverse events/effects
Primary endpoint: Dose optimisation or interruption of treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Serious adverse events related to complicated Crohn's disease
Endpoint domain: Adverse events/effects
Primary endpoint: Responder rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Sustained complete spontaneous bowel motion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mental score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: survival at 24 months
Endpoint domain: Mortality/survival
Primary endpoint: Probability of survival on treatment
Endpoint domain: Mortality/survival
Primary endpoint: ACR 20% responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of adhesive baseplate replacements
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Patient satisfaction with neck brace
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PPI at 120-ms intervals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: costs for anaesthetics
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: subjective anxiety during procedures
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: TOH test performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of lymph node metastases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Insulinaemic indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean scores of intervention group
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Objective understanding
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Subjective understanding
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: recurrent ipsilateral ischemic stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Discontinuance of inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Decrease in leucocytes and lymphocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Increase in undamaged cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of autistic symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in self-esteem
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: DN4 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BQ scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ulcer-free rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Best Corrected Distance Visual Acuity (BCDVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: QT dispersion (QTd) reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Treatment success at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Pulmonary Artery Systolic Pressure (PASP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Right Ventricular Fractional Area Change (RV-FAC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: BUT (Break-up Time)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chance of remaining a non-smoker
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: size of capsaicin flare
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to initial flare response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy for CHF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Ratio of urinary albumin to creatinine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of freedom from AF
Endpoint domain: Mortality/survival
Primary endpoint: Mean ablation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Postoperative ventilation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean time to ETI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived ease of use of VL
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived feasibility of DL in HazMat scenario
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of predicted FEV(1) postbronchoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean increase in QTc interval from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Adverse events after gadobenate dimeglumine injection
Endpoint domain: Adverse events/effects
Primary endpoint: disabling symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total number of sick days
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: sick-leave profile
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Arterial oxygen pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Arterial pressure of CO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time difference from the end of tonsillectomy to T90 neuromuscular block recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum operation room time saving per each tonsillectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decline in Brief Psychiatric Rating Scale (BPRS) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decline in BPRS positive symptom subscale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decline in HAMD-21 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Marital adjustment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Postoperative demand for analgesics
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: FLACC pain scale scores at 20 minutes post-operatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor Assessment Scale total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Barthel Index of Activities of Daily Living total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete regression of subdural effusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean sum score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of time with gastric pH > 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Median gastric pH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Renal resistive index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Postoperative symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of kidney pain events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement of QoLs
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: increase in Qmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exclusive breastfeeding at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean weight-for-age Z-scores at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of diarrhoea in exclusively breastfed infants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of hospitalization due to respiratory syncytial virus (RSV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total-Cholesterol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: time to return to training
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to return to competition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: resumption of sports activities at the former level
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: percentage increase of paced RR intervals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: fall in diastolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Identification of RLS using TCD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of biopsy-proven grade II or greater acute rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Laryngoscopic appearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neurocognitive and neurologic function assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduction in probing depth (PD) at teeth with site(s) with PD ≥ 4 mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Period of abdominal pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Liver and kidney function (plasma alanine aminotransferase, aspartate aminotransferase, and creatinine levels)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: haemorrhage
Endpoint domain: Adverse events/effects
Primary endpoint: Progression of posterior subcapsular cataract by 2 or more grades
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Progression of cortical cataracts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: CBG concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Cortisol free fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: HNE activity in blood after zymosan challenge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NAb concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: symptom success rates
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pain on motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total daily insulin dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: success of pregnancy termination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Improvement in velopharyngeal gap at closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in velar excursion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Life years (LY) gained
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life